Burgermeister, E., Höde, P., Betge, J., Gutting, T., Merkel, A., Wu, W., . . . Ebert, M. P. (2017). Epigenetic silencing of tumor suppressor candidate 3 confers adverse prognosis in early colorectal cancer. Oncotarget.
Chicago Style CitationBurgermeister, Elke, et al. "Epigenetic Silencing of Tumor Suppressor Candidate 3 Confers Adverse Prognosis in Early Colorectal Cancer." Oncotarget 2017.
Cita MLABurgermeister, Elke, et al. "Epigenetic Silencing of Tumor Suppressor Candidate 3 Confers Adverse Prognosis in Early Colorectal Cancer." Oncotarget 2017.
Atenció: Aquestes cites poden no estar 100% correctes.